Clinical Variability of Family Members with the C104R Mutation in Transmembrane Activator and Calcium Modulator and Cyclophilin Ligand Interactor (TACI)

A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults

(2012) Birgit Thierry-Carstensen et al.   VACCINE

The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice

(2011) Chiara Bacchelli et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

TNFRSF13B/TACI Alterations in Greek Patients with Antibody Deficiencies

(2011) Matthaios Speletas et al.   JOURNAL OF CLINICAL IMMUNOLOGY

CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency

(2010) Menno C. van Zelm et al.   JOURNAL OF CLINICAL INVESTIGATION

Novel Mutations in TACI (TNFRSF13B) Causing Common Variable Immunodeficiency

(2009) Javad Mohammadi et al.   JOURNAL OF CLINICAL IMMUNOLOGY

CD20 deficiency in humans results in impaired T cell–independent antibody responses

(2009) Taco W. Kuijpers et al.   JOURNAL OF CLINICAL INVESTIGATION

Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes

(2008) U. Salzer et al.   BLOOD

TACImutations and disease susceptibility in patients with common variable immunodeficiency

(2008) A. E. J. Poodt et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Infections in 252 Patients with Common Variable Immunodeficiency

(2008) Eric Oksenhendler et al.   CLINICAL INFECTIOUS DISEASES